Literature DB >> 21104161

Association of novel mutations and haplotypes in the preS region of hepatitis B virus with hepatocellular carcinoma.

Jia-Xin Xie1, Jun Zhao, Jian-Hua Yin, Qi Zhang, Rui Pu, Wen-Ying Lu, Hong-Wei Zhang, Hong-Yang Wang, Guang-Wen Cao.   

Abstract

The association of viral mutations and haplotypic carriages with mutations in the preS region of hepatitis B virus (HBV) genotypes B and C with hepatocellular carcinoma (HCC) is of great significance for the prediction of this malignancy, but it remains obscure. We analyzed the preS sequences of HBV genotypes B and C from 1172 HBV-infected subjects including 231 patients with HCC. As compared with the HBV-infected subjects without HCC, C2875T, G2946C, A3054C, C3060A, T3066C, C3116T, A3120C, G3191A, A1C, C7A, C10A, A31C, C76T, G105C, and G147C in both genotypes were significantly associated with increased risks of HCC. C2875A, G2950A, G2951A, A3054T, C3060T, T3066A, T3069G, A3120T, and G3191C were significantly associated with increased risks of HCC in genotype C, whereas these mutations were inversely associated with HCC in genotype B. Multivariate regression analyses showed that C76A/T was a novel factor independently associated with an increased risk of HCC, as compared with those without HCC. The frequencies of haplotypes 2964A-3116T-preS2 start codon wild-type-7C, 2964C-3116T-7A-76C, and 2964A-3116T-7C-76A/T were significantly higher in the patients with HCC (P<0.001), whereas a haplotypic carriage with a single mutation and another three wildtypes were inversely associated with HCC. Conclusively, the association of HBV mutations in the preS region with HCC depends on HBV genotype and haplotypic carriage with two or more mutations that are each associated with an increased risk of HCC independently.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21104161     DOI: 10.1007/s11684-010-0160-0

Source DB:  PubMed          Journal:  Front Med China        ISSN: 1673-7342


  21 in total

1.  Improved multiplex-PCR to identify hepatitis B virus genotypes A-F and subgenotypes B1, B2, C1 and C2.

Authors:  Jinsong Chen; Jianhua Yin; Xiaojie Tan; Haiqin Zhang; Hongwei Zhang; Beichuan Chen; Wenjun Chang; Stephan Schaefer; Guangwen Cao
Journal:  J Clin Virol       Date:  2007-01-16       Impact factor: 3.168

2.  Clinical relevance and public health significance of hepatitis B virus genomic variations.

Authors:  Guang-Wen Cao
Journal:  World J Gastroenterol       Date:  2009-12-14       Impact factor: 5.742

3.  Distribution and hepatocellular carcinoma-related viral properties of hepatitis B virus genotypes in Mainland China: a community-based study.

Authors:  Jianhua Yin; Hongwei Zhang; Yongchao He; Jiaxin Xie; Shijian Liu; Wenjun Chang; Xiaojie Tan; Chunying Gu; Wei Lu; Hongyang Wang; Shengli Bi; Fuqiang Cui; Xiaofeng Liang; Stephan Schaefer; Guangwen Cao
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-02-16       Impact factor: 4.254

4.  Pre-S mutant surface antigens in chronic hepatitis B virus infection induce oxidative stress and DNA damage.

Authors:  Yi-Hsuan Hsieh; Ih-Jen Su; Hui-Ching Wang; Wen-Wei Chang; Huan-Yao Lei; Ming-Derg Lai; Wen-Tsan Chang; Wenya Huang
Journal:  Carcinogenesis       Date:  2004-06-03       Impact factor: 4.944

5.  Role of hepatitis B virus genotype mixture, subgenotypes C2 and B2 on hepatocellular carcinoma: compared with chronic hepatitis B and asymptomatic carrier state in the same area.

Authors:  Jianhua Yin; Hongwei Zhang; Chengzhong Li; Chunfang Gao; Yongchao He; Yujia Zhai; Peng Zhang; Ling Xu; Xiaojie Tan; Jinsong Chen; Shuqun Cheng; Stephan Schaefer; Guangwen Cao
Journal:  Carcinogenesis       Date:  2008-01-12       Impact factor: 4.944

6.  High prevalence of hepatitis B virus pre-S mutation and its association with hepatocellular carcinoma in Qidong, China.

Authors:  Zhigang Cao; Xin Bai; Xia Guo; Yan Jin; Gengsun Qian; Hong Tu
Journal:  Arch Virol       Date:  2008-08-24       Impact factor: 2.574

Review 7.  Hepatitis B-related hepatocellular carcinoma: epidemiological characteristics and disease burden.

Authors:  V T T Nguyen; M G Law; G J Dore
Journal:  J Viral Hepat       Date:  2009-03-17       Impact factor: 3.728

8.  Associations between hepatitis B virus mutations and the risk of hepatocellular carcinoma: a meta-analysis.

Authors:  Shijian Liu; Hongwei Zhang; Chunying Gu; Jianhua Yin; Yongchao He; Jiaxin Xie; Guangwen Cao
Journal:  J Natl Cancer Inst       Date:  2009-07-02       Impact factor: 13.506

9.  Hepatitis B virus pre-S deletion mutations are a risk factor for hepatocellular carcinoma: a matched nested case-control study.

Authors:  Zhong-Liao Fang; Caroline A Sabin; Bai-Qing Dong; Shao-Chao Wei; Qin-Yan Chen; Kong-Xiong Fang; Jin-Ye Yang; Jian Huang; Xue-Yan Wang; Tim J Harrison
Journal:  J Gen Virol       Date:  2008-11       Impact factor: 3.891

10.  Risk factors for acute hepatitis B and its progression to chronic hepatitis in Shanghai, China.

Authors:  H W Zhang; J H Yin; Y T Li; C Z Li; H Ren; C Y Gu; H Y Wu; X S Liang; P Zhang; J F Zhao; X J Tan; W Lu; S Schaefer; G W Cao
Journal:  Gut       Date:  2008-08-28       Impact factor: 23.059

View more
  8 in total

Review 1.  Antiviral treatment to prevent chronic hepatitis B or C-related hepatocellular carcinoma.

Authors:  Li-Ping Chen; Jun Zhao; Yan Du; Yi-Fang Han; Tong Su; Hong-Wei Zhang; Guang-Wen Cao
Journal:  World J Virol       Date:  2012-12-12

2.  Genome-wide association studies: inherent limitations and future challenges.

Authors:  Yan Du; Jiaxin Xie; Wenjun Chang; Yifang Han; Guangwen Cao
Journal:  Front Med       Date:  2012-11-03       Impact factor: 4.592

3.  HLA-DP polymorphisms affect the outcomes of chronic hepatitis B virus infections, possibly through interacting with viral mutations.

Authors:  Qi Zhang; Jianhua Yin; Yuwei Zhang; Yang Deng; Xiaowei Ji; Yan Du; Rui Pu; Yifang Han; Jun Zhao; Xue Han; Hongwei Zhang; Guangwen Cao
Journal:  J Virol       Date:  2013-09-04       Impact factor: 5.103

4.  Relative Abundance of Integrant-Derived Viral RNAs in Infected Tissues Harvested from Chronic Hepatitis B Virus Carriers.

Authors:  Natalia Freitas; Tetyana Lukash; Sumedha Gunewardena; Benjamin Chappell; Betty L Slagle; Severin O Gudima
Journal:  J Virol       Date:  2018-04-27       Impact factor: 5.103

Review 5.  Factors predicting occurrence and prognosis of hepatitis-B-virus-related hepatocellular carcinoma.

Authors:  Yi-Fang Han; Jun Zhao; Li-Ye Ma; Jian-Hua Yin; Wen-Jun Chang; Hong-Wei Zhang; Guang-Wen Cao
Journal:  World J Gastroenterol       Date:  2011-10-14       Impact factor: 5.742

6.  Association of miRNA-122-binding site polymorphism at the interleukin-1 α gene and its interaction with hepatitis B virus mutations with hepatocellular carcinoma risk.

Authors:  Yan Du; Xue Han; Rui Pu; Jiaxin Xie; Yuwei Zhang; Guangwen Cao
Journal:  Front Med       Date:  2014-04-21       Impact factor: 4.592

7.  Genotypes, mutations, and viral load of hepatitis B virus and the risk of hepatocellular carcinoma: HBV properties and hepatocarcinogenesis.

Authors:  Qi Zhang; Guangwen Cao
Journal:  Hepat Mon       Date:  2011-02       Impact factor: 0.660

8.  Deep sequencing of HBV pre-S region reveals high heterogeneity of HBV genotypes and associations of word pattern frequencies with HCC.

Authors:  Xin Bai; Jian-An Jia; Meng Fang; Shipeng Chen; Xiaotao Liang; Shanfeng Zhu; Shuqin Zhang; Jianfeng Feng; Fengzhu Sun; Chunfang Gao
Journal:  PLoS Genet       Date:  2018-02-23       Impact factor: 5.917

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.